Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis M Tebit

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibilityAndré F A Santos, Denis M Tebit, Matthew S Lalonde, et al.
Journal of Medical Virology|August 22, 2009
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina FasoDenis M Tebit, Lassana Sangaré, Fabrice Tiba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina FasoDenis M Tebit, Lassana Sangaré, Aline Makamtse, et al.
Frontiers in Public Health|January 4, 2024
Molecular epidemiology of SARS-CoV-2 in Northern South Africa: wastewater surveillance from January 2021 to May 2022Lisa Arrah Mbang Tambe, Phindulo Mathobo, Nontokozo D Matume, et al.
Plos Pathogens|April 4, 2009
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseRyan M Troyer, John McNevin, Yi Liu, et al.
Ebiomedicine|January 12, 2024
Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humansDenis M Tebit, Gabrielle Nickel, Richard Gibson, et al.
Immunity, Inflammation and Disease|December 6, 2017
Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8<sup>+</sup> T cellsLoveline N Ngu, Nadesh N Nji, Georgia Ambada, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibilityAndré F A Santos, Denis M Tebit, Matthew S Lalonde, et al.
Journal of Medical Virology|August 22, 2009
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina FasoDenis M Tebit, Lassana Sangaré, Fabrice Tiba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina FasoDenis M Tebit, Lassana Sangaré, Aline Makamtse, et al.
Frontiers in Public Health|January 4, 2024
Molecular epidemiology of SARS-CoV-2 in Northern South Africa: wastewater surveillance from January 2021 to May 2022Lisa Arrah Mbang Tambe, Phindulo Mathobo, Nontokozo D Matume, et al.
Plos Pathogens|April 4, 2009
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseRyan M Troyer, John McNevin, Yi Liu, et al.
Ebiomedicine|January 12, 2024
Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humansDenis M Tebit, Gabrielle Nickel, Richard Gibson, et al.
Immunity, Inflammation and Disease|December 6, 2017
Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8<sup>+</sup> T cellsLoveline N Ngu, Nadesh N Nji, Georgia Ambada, et al.
Pageof 4